How to conduct a dose response trial of Parkinson's disease medication

Australian Journal of Physiotherapy

Volumn 44, Issue 2, 1998, Pages 131-133

  Morris, Meg ^a,b   Churchyard, Andrew ^a   Lansek, Robert ^a,c  

^a Kingston Centre   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Drug induced; Dyskinesia; Medication systems; Movement disorders; Parkinson disease; Physical therapy

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; BENSERAZIDE PLUS LEVODOPA; LEVODOPA;

ARTICLE; DYSKINESIA; HUMAN; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PHYSIOTHERAPIST; PHYSIOTHERAPY; RATING SCALE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031779751     PISSN: 00049514     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0004-9514(14)60373-1     Document Type: Article

References (6)

1. Hoehn MM and Yahr MD (1967): Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
2. Iansek R (1997): Clinical Rating Scale for Dyskinesia. Melbourne: Kingston Centre.
3. Kempster PA, Frankel JP, Bovingdon M, Webster R, Lees AJ and Stern GM (1989): Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. Journal of Neurology, Neurosuergery and Psychiatry 52: 718-723.
4. Morris M, Iansek R and Churchyard A (1998): The role of physiotherapy in quantifying movement fluctuations in Parkinson's disease. Australian Journal of Physiotherapy 44: 117-121.
5. Podsialdo D and Richardson S (1991): The timed "Up & Go": a test of basic functional mobility for frail elderly persons. Journal of the American Geriatric Society 39: 142-148.
6. Tiffin J (1979): Purdue pegboard examiner manual. Lafayette Instruments Company, Reorder No. 7-435. Lafayette 2.